Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factorsA. Ngeuleu, N. Hajjaj‐Hassouni, F. Allali et al.|Rheumatology International|2017Cited by 114
Prevalence and clinical characteristics of tuberculosis in rheumatoid arthritis patientsF. Allali, N. Hajjaj‐Hassouni, H. Rkain et al.|Clinical Rheumatology|2004Cited by 8
AB0365 Sleep Disorders in Moroccan Patients with Rheumatoid ArthritisT. Lakhdar, N. Hajjaj‐Hassouni, F. Allali et al.|Annals of the Rheumatic Diseases|2014Cited by 4
AB0486 ONE-YEAR DIRECT COSTS OF BIOLOGICAL THERAPY IN ANKYLOSING SPONDYLITIS AND ITS PREDICTIVE FACTORS: DATA FROM THE MOROCCAN RBSMR REGISTRYSlah Bahloul, F. Allali, H. Rkain et al.|Annals of the Rheumatic Diseases|2021Cited by 2
Indirect costs assessment and intangible costs description of rheumatoid arthritis patients with biological therapy in Morocco: <scp>ECORAM</scp> StudyHanae Zarrik, Samir Ahid, Abha Cherkani Hassani et al.|International Journal of Rheumatic Diseases|2024Cited by 2